Algorhythm Holdings, Inc. (RIME) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on August 21, 2025. Algorhythm Holdings, Inc. (the "Company") entered into a material definitive agreement for a private placement of securities and reported the resignation of a director. The Company is incorporated in Delaware and trades on The Nasdaq Capital Market under the symbol "RIME."
Key Financial Metrics and Transaction Details
The filing details a secured pre-paid purchase facility rather than standard operating financial results. Key transaction metrics include:
- Total Facility Size: Up to $20,000,000 in aggregate pre-paid purchases.
- Initial Funding: $4,390,000 principal amount (Initial Pre-Paid Purchase).
- Net Proceeds (Initial): Approximately $3,990,000 after deducting a $360,000 original issue discount (OID) and $30,000 in transaction expenses.
- Interest Rate: 9% per annum on outstanding balances.
- Maturity: Three years from the closing date.
- Commitment Shares: 95,694 shares of Common Stock issued to the Investor as commitment consideration.
- Placement Agent Fees: 8% of gross proceeds plus $40,000 in reimbursed legal fees.
- Collateral: Obligations are secured by all assets of the Company and guaranteed by operating subsidiaries.
Material Changes and Terms
The Company established a two-year commitment period allowing for additional pre-paid purchases in increments of at least $250,000, subject to a $3,000,000 cap on the total outstanding balance of all pre-paid purchases. The agreement includes a "pay-to-play" feature where the Investor may purchase Common Stock at 90% of the lowest daily volume-weighted average price (VWAP) over the 10 trading days prior to the purchase notice, subject to a 9.99% beneficial ownership limit and a stated floor price. Prepayment of the facility requires a 110% premium on the portion prepaid. In the event of default, the outstanding balance increases by 7.5%, and the interest rate accelerates to the lesser of 18% per annum or the maximum permitted by law.
Guidance, Risks, and Corporate Governance
Management Commentary and Use of Proceeds: Proceeds are designated for working capital and other corporate purposes. The Company is required to file a Form S-1 registration statement within 30 days to register the resale of commitment shares and shares issuable under the facility.
Risks and Contingencies: The issuance of shares under the facility is contingent upon obtaining stockholder approval under Nasdaq Listing Rule 5635(d). If approval is not obtained within 75 days, the Company must seek it every 90 days thereafter. Until approval is granted, share issuance is capped at the numerical threshold required by the rule.
Corporate Governance Change: Joseph Kling resigned from the Board of Directors and all committee memberships (Audit, Compensation, and Nominating and Corporate Governance) effective August 21, 2025. The resignation was not due to any disagreement with the Company.
Investor Verification Checklist
- Verify the status of the Form S-1 registration statement required within 30 days of August 21, 2025.
- Confirm whether stockholder approval under Nasdaq Rule 5635(d) has been obtained to allow full share issuance.
- Review the Security Agreement (Exhibit 10.3) to understand the specific scope of assets pledged as collateral.
- Monitor the Company's cash position to assess the ability to service the 9% interest and potential 110% prepayment penalty.
- Check for any subsequent filings regarding the resignation of Joseph Kling and the appointment of a replacement director.